Clovis Oncology Inc EV/Sales
What is the EV/Sales of Clovis Oncology Inc?
The EV/Sales of Clovis Oncology Inc is 4.91
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to Clovis Oncology Inc
Companies with ev/sales similar to Clovis Oncology Inc
- Elecon Engineering has EV/Sales of 4.90
- Hamborner REIT AG has EV/Sales of 4.90
- Dun & Bradstreet has EV/Sales of 4.90
- Hut 8 Mining has EV/Sales of 4.90
- Wall has EV/Sales of 4.91
- Trainline Plc has EV/Sales of 4.91
- Clovis Oncology Inc has EV/Sales of 4.91
- Omkar Speciality Chemicals has EV/Sales of 4.91
- Diversified Gas & Oil PLC has EV/Sales of 4.91
- Tata Consultancy Services has EV/Sales of 4.91
- Victory Securities () has EV/Sales of 4.91
- Steris Plc has EV/Sales of 4.91
- Diageo Plc has EV/Sales of 4.92